Free · 13,591 studies indexed

lighttherapyresearch.com is a free index of research on photobiomodulation and light therapy, gathered from the world’s journals and trial registries.

Sections
Skin & Wound Healing

Low-dose photodynamic therapy promotes angiogenic potential and increases immunogenicity of human mesenchymal stromal cells

Low-dose PDT in MSCs significantly inhibited secretion of CCL2 (MCP-1) potentially limiting infiltration of pro-tumorigenic macrophages.

Excerpt from the paper’s abstract. Read the full paper for the details.

AI-generated summary

The authors studied how low-dose photodynamic therapy affects human mesenchymal stromal cells grown in vitro, a model of tumor stroma. They report that the treatment increased reactive oxygen species, reduced cell motility, and raised secretion of several proangiogenic factors, improving the cells' ability to promote angiogenesis. The findings come from an in vitro study, so the clinical relevance is unclear.

Who or what was studied
Human mesenchymal stromal cells studied in an in vitro model
Limits stated in the abstract
The study is an in vitro cell model, so its findings may not translate directly to tumors in patients.

Written by an AI model from this paper’s abstract only and checked automatically against it, but it can still be wrong. It is not medical advice. Read the full paper. See the editorial policy.

Abstract

The full abstract is not shown here because it is protected by the publisher’s copyright. Read it on linkinghub.elsevier.com.

Record from PubMed, a service of the National Library of Medicine.

How to read a single study: what to check before relying on this kind of research.

Terms in this paper: Photodynamic therapy, Dose, Reactive oxygen species, Angiogenesis. Each links to its definition in the glossary.

A summary of published research, not medical advice. One study rarely settles a question. See the disclaimer and how to read research.

Related studies